Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease

K. Affolter, M. Tamm, K. Jahn, J. Halter, J. Passweg, H. Hirsch, D. Stolz (Basel, Switzerland)

Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Session: Cells, biofilms and biomarkers in respiratory infections
Session type: Thematic Poster Session
Number: 2502

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Affolter, M. Tamm, K. Jahn, J. Halter, J. Passweg, H. Hirsch, D. Stolz (Basel, Switzerland). Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease. Eur Respir J 2014; 44: Suppl. 58, 2502

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fungal PCR in the bronchoalveolar lavage for diagnosing invasive fungal disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015

Utility and cost of routine bronchoalveolar lavage in diagnosing pulmonary fungal infections
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013


Bronchial wash/lavage and etiologic diagnosis on immunocompromised patients
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013

Pulmonary nocardiosis-always an opportunist infection?
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015


Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Diagnostic value of galactomannan in bronchoalveolar lavage for invasive pulmonary aspergillosis in immunocompromised children
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009


Aspergillus-PCR in bronchoalveolar lavage for detection of invasive fungal disease in immunocompromised patients
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Role of bronchoalveolar lavage in new sputum smear negative pulmonary tuberculosis patients
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016


Importance of flexible broncoscopy in immunocompromised children with pulmonary infections
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014


Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Endobronchial biopsies in children with protracted bacterial bronchitis
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013

Comparison of PCR and culture based detection of pathogens in bronchoalveolar fluid in neutropenic children
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013

Evaluation of bronchoscopic findings and bronchoalveolar lavage (BAL) fluid cytology with regard to BAL fluid microbiology in critically ill patients.
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015


Clinical approach to pulmonary sarcoidosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016


Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013



Diagnostic yield of bronchoalveolar lavage in hematological malignancies
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013

Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014